ARSUF
Price
$20.03
Change
-$0.82 (-3.93%)
Updated
Oct 29 closing price
Capitalization
1.27B
AVCNF
Price
$0.19
Change
-$0.01 (-5.00%)
Updated
Jun 25 closing price
Capitalization
18.52M
Interact to see
Advertisement

ARSUF vs AVCNF

Header iconARSUF vs AVCNF Comparison
Open Charts ARSUF vs AVCNFBanner chart's image
Fagron SA
Price$20.03
Change-$0.82 (-3.93%)
Volume$425
Capitalization1.27B
Avicanna
Price$0.19
Change-$0.01 (-5.00%)
Volume$36.88K
Capitalization18.52M
ARSUF vs AVCNF Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARSUF vs. AVCNF commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSUF is a Hold and AVCNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ARSUF: $20.03 vs. AVCNF: $0.19)
Brand notoriety: ARSUF and AVCNF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ARSUF: 100% vs. AVCNF: 7%
Market capitalization -- ARSUF: $1.27B vs. AVCNF: $18.52M
ARSUF [@Pharmaceuticals: Other] is valued at $1.27B. AVCNF’s [@Pharmaceuticals: Other] market capitalization is $18.52M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARSUF’s FA Score shows that 1 FA rating(s) are green whileAVCNF’s FA Score has 0 green FA rating(s).

  • ARSUF’s FA Score: 1 green, 4 red.
  • AVCNF’s FA Score: 0 green, 5 red.
According to our system of comparison, ARSUF is a better buy in the long-term than AVCNF.

Price Growth

ARSUF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while AVCNF (@Pharmaceuticals: Other) price change was +7.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +14.45%, and the average quarterly price growth was +91.39%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
ARSUF($1.27B) has a higher market cap than AVCNF($18.5M). ARSUF YTD gains are higher at: 0.000 vs. AVCNF (-6.358). ARSUF has higher annual earnings (EBITDA): 136M vs. AVCNF (-13.98M). ARSUF has more cash in the bank: 119M vs. AVCNF (222K). AVCNF has less debt than ARSUF: AVCNF (1.81M) vs ARSUF (385M). ARSUF has higher revenues than AVCNF: ARSUF (727M) vs AVCNF (4.18M).
ARSUFAVCNFARSUF / AVCNF
Capitalization1.27B18.5M6,843%
EBITDA136M-13.98M-973%
Gain YTD0.000-6.358-
P/E Ratio17.83N/A-
Revenue727M4.18M17,392%
Total Cash119M222K53,604%
Total Debt385M1.81M21,294%
FUNDAMENTALS RATINGS
ARSUF vs AVCNF: Fundamental Ratings
ARSUF
AVCNF
OUTLOOK RATING
1..100
4623
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5899
PRICE GROWTH RATING
1..100
5558
P/E GROWTH RATING
1..100
52100
SEASONALITY SCORE
1..100
2450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARSUF's Valuation (28) in the null industry is in the same range as AVCNF (54). This means that ARSUF’s stock grew similarly to AVCNF’s over the last 12 months.

ARSUF's Profit vs Risk Rating (100) in the null industry is in the same range as AVCNF (100). This means that ARSUF’s stock grew similarly to AVCNF’s over the last 12 months.

ARSUF's SMR Rating (58) in the null industry is somewhat better than the same rating for AVCNF (99). This means that ARSUF’s stock grew somewhat faster than AVCNF’s over the last 12 months.

ARSUF's Price Growth Rating (55) in the null industry is in the same range as AVCNF (58). This means that ARSUF’s stock grew similarly to AVCNF’s over the last 12 months.

ARSUF's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for AVCNF (100). This means that ARSUF’s stock grew somewhat faster than AVCNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVO7.110.29
+4.18%
CervoMed
RTX142.671.29
+0.91%
RTX Corp
DVAX9.940.08
+0.81%
Dynavax Technologies Corp
LSCC50.50-0.31
-0.61%
Lattice Semiconductor Corp
CLOV2.79-0.05
-1.76%
Clover Health Investments Corp

ARSUF and

Correlation & Price change

A.I.dvisor tells us that ARSUF and CRDL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
CRDL - ARSUF
22%
Poorly correlated
+1.38%
AVCNF - ARSUF
12%
Poorly correlated
-1.91%
ALID - ARSUF
8%
Poorly correlated
N/A
BSPK - ARSUF
2%
Poorly correlated
+67.50%
BIOGY - ARSUF
2%
Poorly correlated
N/A
More

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
-1.91%
PRFX - AVCNF
20%
Poorly correlated
-1.63%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
+67.50%
APNHY - AVCNF
7%
Poorly correlated
-0.38%
BKUH - AVCNF
5%
Poorly correlated
N/A
More